DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,443,000 | -22.5% | 30,000 | -25.0% | 0.14% | -15.8% |
| Q2 2023 | $9,600,000 | +245.0% | 40,000 | +223.5% | 0.16% | +371.4% |
| Q1 2021 | $2,783,000 | +95.6% | 12,365 | -14.9% | 0.04% | +20.7% |
| Q1 2018 | $1,423,000 | -88.8% | 14,534 | -89.4% | 0.03% | -87.4% |
| Q4 2017 | $12,668,000 | -17.2% | 136,482 | -23.5% | 0.23% | -22.0% |
| Q3 2017 | $15,303,000 | -15.6% | 178,395 | -17.0% | 0.30% | -47.0% |
| Q2 2017 | $18,135,000 | +69.4% | 214,900 | +71.6% | 0.56% | +93.1% |
| Q1 2017 | $10,708,000 | +3.6% | 125,201 | -5.7% | 0.29% | -14.0% |
| Q4 2016 | $10,333,000 | +239.9% | 132,745 | +242.3% | 0.34% | +223.1% |
| Q3 2016 | $3,040,000 | +715.0% | 38,781 | +949.3% | 0.10% | +593.3% |
| Q2 2016 | $373,000 | -94.6% | 3,696 | -95.0% | 0.02% | -94.6% |
| Q1 2016 | $6,963,000 | +92.8% | 73,407 | +88.8% | 0.28% | +150.0% |
| Q4 2015 | $3,611,000 | -62.4% | 38,883 | -65.5% | 0.11% | -75.1% |
| Q3 2015 | $9,607,000 | -72.7% | 112,747 | -72.6% | 0.45% | -40.8% |
| Q2 2015 | $35,239,000 | +78.9% | 411,723 | +77.4% | 0.76% | +75.1% |
| Q1 2015 | $19,700,000 | -2.5% | 232,033 | -1.5% | 0.43% | -32.0% |
| Q4 2014 | $20,195,000 | -2.8% | 235,623 | -13.8% | 0.64% | +31.3% |
| Q3 2014 | $20,774,000 | -22.3% | 273,418 | -19.4% | 0.48% | -24.7% |
| Q2 2014 | $26,721,000 | +1003.3% | 339,405 | +951.0% | 0.64% | +1188.0% |
| Q1 2014 | $2,422,000 | +213.7% | 32,292 | +222.9% | 0.05% | +316.7% |
| Q4 2013 | $772,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |